Errata “Antenatal Corticosteroids Prior to 24 Weeks' Gestation and Neonatal Outcome of Extremely Low Birth Weight Infants”

The publisher regrets an error in the table titles of Tables [1] and [2] in the above article in the American Journal of Perinatology, Volume 27, Number 1, 2010, p. 63. The correct tables appear below.

Table 1 Maternal and Delivery Characteristics of Singleton Pregnancies Delivered at 230/7 to 256/7 Weeks' Gestation Characteristics Steroid-Treated (n = 82) Controls (n = 35) p Value Maternal age (y) 28.7 ± 7.1 26.9 ± 7.2 0.22 Black/white/other (%) 65/23/13 66/17/17 0.90 Preeclampsia (%) 9.8 2.9 0.37 Preterm labor (%) 77.8 68.9 0.61 Chorioamnionitis (%) 76.8 54.3 0.03 Premature rupture of membranes (%) 59.8 34.3 0.02 Cesarean section (%) 47.6 40.0 0.58 Gestational age at ANS dose (wk) 23.5 ± 0.5 Data expressed as percentage and mean ± standard deviation. ANS, antenatal corticosteroid.

Table 2 Antenatal Corticosteroid Exposure: Outcome of Singleton Infants at 230/7 to 256/7 Weeks' Gestation Characteristics Steroid-Treated (n = 82) Controls (n = 35) p Value Birth weight (g) 702 ± 165 657 ± 150 0.14 Gestational age (wk) 24.3 ± 1.0 24.1 ± 1.1 0.30 Sex (% male/female) 54.9/45.1 57.1/42.9 0.84 1-min Apgar <7 (%) 68.3 88.6 0.02 5-min Apgar <7 (%) 30.5 51.4 0.03 Death before discharge (%) 29.3 62.9 <0.001 IVH (grade 1 and 2, %) 45.5 43.5 0.99 IVH (grade 3 and 4, %) 16.7 36.0 <0.05 RDS (%) 100 100 NA PDA treated with indomethacin (%) 50.7 72.0 0.07 Sepsis (%) 60.7 52.2 0.48 NEC stage 3 and 4 (%) 0.0 6.9 0.57 Pressors (%) 54.4 64.5 0.35 ROP (stage 3–4) 32.7 23.1 0.74 BPD at 36 weeks' PCA (%) 71.9 76.9 0.99 Duration of vent (d) 51 ± 37 49 ± 21 0.80 Duration of O2 (d) 55 ± 38 53 ± 38 0.72 Length of stay (d) 117 ± 52 108 ± 24 0.41 Data expressed as percentage and mean ± SD. PDA, patent ductus arteriosus; NEC, necrotizing enterocolitis; IVH, intraventricular hemorrhage; ROP, retinopathy of prematurity; BPD, bronchopulmonary dysplasia; PCA, postconceptional age.